- Projects & figures
- News & Events
- Managing your project
- About ERC
An ERC-funded project has significantly increased understanding of the crucial role that microorganisms in the gut play in maintaining health. The findings have since led to a patent, as well as a follow-on project that could one day steer the way to new targeted treatments for diseases, including cancer.
For the first time ever, two ERC grantees, Prof. Luca G. Guidotti and Dr Matteo Iannacone, have observed in vivo how specific white blood cells, so-called cytotoxic T lymphocytes, identify, target and attack liver cells that are infected with the hepatitis B virus. To witness these immune cells in action in real time, the two scientists developed advanced, dynamic imaging techniques. An estimated 240 million people are chronically infected with hepatitis B worldwide. This discovery, published today in the scientific journal Cell, opens new horizons for the development of novel therapies.
Many of the electronic gadgets we currently take for granted already use ‘spintronics’ – for instance, the high-capacity hard disks that we find in today’s laptops. With the help of her ERC funding, Professor Roberta Sessoli is advancing our knowledge of the fundamental properties of molecular magnets and quantum spin, research which may lead to new molecular spin-based technologies. Prof Sessoli will attend the conference ERC – 5 years of achievement and the Italian National Information Day on the ERC funding schemes in Rome on 25 June 2012.